[Physiological activity of kappa-casein glycomacropeptide]

Area of Science:

• Biochemistry
• Peptide Chemistry
• Gastroenterology

Background:

• Kappa-casein glycomacropeptide (GMP) is a byproduct of cheese production.
• GMP has been investigated for various physiological effects.
• The specific bioactive components within GMP require further elucidation.

Purpose of the Study:

• To isolate and characterize a low molecular weight peptide fragment from GMP.
• To evaluate the gastric secretion inhibitory activity of this peptide fragment.
• To determine whether the fragment or the whole GMP molecule is responsible for the observed inhibition.

Main Methods:

• Gel chromatography using Sephadex G-25 superfine was employed for peptide isolation.
• Intravenous administration was used to deliver the peptide fragment and GMP preparation.
• Gastric secretion levels were measured to assess inhibitory effects.

Main Results:

• A low molecular peptide fragment (molecular weight 700-2,000) was successfully isolated from GMP.
• The isolated peptide fragment demonstrated a more distinct inhibition of gastric secretion compared to the initial GMP preparation.
• The whole GMP molecule showed less potent inhibitory activity than its isolated fragment.

Conclusions:

• The inhibitory effect on gastric secretion attributed to GMP is primarily mediated by a specific low molecular weight peptide fragment.
• The whole kappa-casein glycomacropeptide molecule is less effective in inhibiting gastric secretion than its isolated bioactive fragment.
• This research identifies a key functional peptide within GMP responsible for gastric secretion modulation.